Assistant Vice President at the University of South Florida, PhD researcher, retired U.S. Navy CDR, saturation diver, and ...

The primary value of placebo controls in clinical trials is the minimization of bias.

Fish oil supplements, delivering higher EPA doses, significantly reduced the number and procoagulant activity of ...

"Unlike other MDMA-Assisted Therapy/Psychedelic Assisted Therapy long-term studies, this will be one of the first that I'm ...

C annabis is regularly found by studies to be the least risky recreational drug and has never been linked to a fatal overdose ...

Alto Neuroscience, Inc. (NYSE: ANRO) reported financial results for the full year ending December 31, 2024, highlighting ...

The FDA has approved Novartis’ Fabhalta (iptacopan) as the first and only treatment for C3 glomerulopathy (C3G). Previously, patients with C3G were forced to rely on supportive care and broad ...

Natural products industry companies share overviews on the latest science on their branded ingredients and formulations to ...

An expert discusses how CheckMate 274 is a phase 3, randomized, double-blind trial evaluating adjuvant nivolumab vs placebo in patients with high-risk muscle-invasive urothelial carcinoma (MIUC) after ...

In the study, treatment with AGA111, a recombinant human bone morphogenetic protein 6 (rhBMP6), led to faster radiographic fusion and a higher fusion success rate, as well as greater improvements in ...